5'-Nucleotidase, Cytosolic III (NT5C3) Peptide
NT5C3
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all NT5C3 products
- NT5C3 (5'-Nucleotidase, Cytosolic III (NT5C3))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-NT5C3 antibody (Catalog #: ARP32185_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- NT5C3 (5'-Nucleotidase, Cytosolic III (NT5C3))
- Synonyms
- 1600024P05Rik Peptide, 2610206B05Rik Peptide, 3110004A18Rik Peptide, AI842776 Peptide, Nt5c3a Peptide, Nt5y Peptide, PN-1 Peptide, PN-I Peptide, PSN1 Peptide, UMPH Peptide, Umph-1 Peptide, Umph1 Peptide, cN-III Peptide, lupin Peptide, p36 Peptide, fb30h07 Peptide, nt5c3 Peptide, wu:fb30h07 Peptide, zgc:66117 Peptide, NT5C3 Peptide, PYN1 Peptide, P5'N-1 Peptide, P5N-1 Peptide, POMP Peptide, UMPH1 Peptide, hUMP1 Peptide, Nt5c3 Peptide, 5'-nucleotidase, cytosolic III Peptide, 5'-nucleotidase, cytosolic IIIA Peptide, cytosolic 5'-nucleotidase 3A Peptide, Nt5c3 Peptide, nt5c3a Peptide, NT5C3A Peptide, LOC534181 Peptide, Nt5c3a Peptide, nt5c3a.L Peptide, Bm1_56095 Peptide
- Background
-
Pyrimidine 5-prime-nucleotidase (P5N), also called uridine 5-prime monophosphate hydrolase (UMPH), catalyzes the dephosphorylation of the pyrimidine 5-prime monophosphates UMP and CMP to the corresponding nucleosides. There are 2 isozymes of pyrimidine 5-prime nucleotidase in red blood cells, referred to as type I (UMPH1) and type II (UMPH2). The 2 enzymes are not separable by electrophoresis in humans but have distinct kinetic properties, and the proteins show no homology. Pyrimidine 5-prime-nucleotidase (P5N, EC 3.1.3.5), also called uridine 5-prime monophosphate hydrolase (UMPH), catalyzes the dephosphorylation of the pyrimidine 5-prime monophosphates UMP and CMP to the corresponding nucleosides. There are 2 isozymes of pyrimidine 5-prime nucleotidase in red blood cells, referred to as type I (UMPH1) and type II (UMPH2, MIM 191720). The 2 enzymes are not separable by electrophoresis in humans but have distinct kinetic properties, and the proteins show no homology.[supplied by OMIM]. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Alias Symbols: MGC27337, MGC87109, MGC87828, P5'N-1, PN-I, PSN1, UMPH, UMPH1, cN-III, NT5C3
Protein Size: 286 - Molecular Weight
- 34 kDa
- Gene ID
- 51251
- NCBI Accession
- NM_016489, NP_057573
-
You are here:
